15 min

Discontinuation of Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia JAMA Oncology Author Interviews

    • Medicine

Interview with Ehab Atallah, MD, author of Assessment of Outcomes After Stopping Tyrosine Kinase Inhibitors Among Patients With Chronic Myeloid Leukemia: A Nonrandomized Clinical Trial

  • American Medical Association, 2020

Interview with Ehab Atallah, MD, author of Assessment of Outcomes After Stopping Tyrosine Kinase Inhibitors Among Patients With Chronic Myeloid Leukemia: A Nonrandomized Clinical Trial

15 min

  • American Medical Association, 2020

More by JAMA Network

JAMA Clinical Reviews
JAMA Clinical Reviews
JAMA Network
JAMA Medical News
JAMA Medical News
JAMA Network
JAMAevidence JAMA Guide to Statistics and Methods
JAMAevidence JAMA Guide to Statistics and Methods
JAMA Network
JAMA Pediatrics Editors' Summary
JAMA Pediatrics Editors' Summary
JAMA Network
JAMA Neurology Author Interviews
JAMA Neurology Author Interviews
JAMA Network
JAMA Psychiatry Author Interviews
JAMA Psychiatry Author Interviews
JAMA Network